JP Morgan Reinstates Underweight on Emergent BioSolutions

Benzinga Newsdesk www.benzinga.com Positive 53.6%

Neg 0% Neu 0% Pos 53.6%

JP Morgan analyst Jessica Fye reinstates Emergent BioSolutions (NYSE:EBS) with a Underweight.

Comments

No comments yet. Be the first!